Kymera Therapeutics, Inc. Rings the Opening Bell

About This Event

Kymera Therapeutics, Inc. (Nasdaq: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Nello Mainolfi, PhD, Founder, President and Chief Executive Officer, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore